It is always best to consult with your healthcare provider before starting GLP, especially if you are taking other medications or have any existing health conditions
Mikkonen TP, Maatta KR, Hukkanen AT, Kokko HI, Torronen AR, Karenlampi SO, Karjalainen RO
LAMP2A, LAMP2B and LAMP2C: similar structures, divergent roles
However, deep down, I still yearned for even the slightest improvement
Long-term safety data continues to accumulate, and a comprehensive 2024 review in Diabetes Care by Daniel Drucker concluded that the overall risk-benefit profile of GLP-1 medicines remains favorable for their approved indications
For example, a study demonstrated that CAR-T cells targeting fibrosis-related antigens successfully restored cardiac function in a mouse model of hypertensive heart injury